2 not yet recruiting, 1 completed. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Not yet recruiting 2, Completed 1 |
| Phase 2 | 2 | Completed 1, Not yet recruiting 1 |
Follow ATRN-119: new trials by email Literature Review of ATRN-119 trials Research Report on ATRN-119
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Combining Neo-adjuvant ATR-inhibition With Nodal SBRT for Early-stage Resectable HPV+ OPSCCs ATRN-119, Stereotactic Body Radiation Therapy (SBRT) - HPV Positive Oropharyngeal Squamous Cell Carcinoma, Squamous Cell Carcinoma | Phase 1 / Phase 2 | Not yet recruiting | Abramson Cancer Center at Penn Medicine | 35 | 2026-08-31 | 2026-07-08 |
| ATRN-119 in Combination With Decitabine in Patients With TP53-Mutated AML or Higher-Risk MDS ATRN-119, Decitabine - Acute Myeloid Leukemia, High-risk Myelodysplastic Syndrome | Phase 1 | Not yet recruiting | Washington University School of Medicine | 27 | 2026-08-31 | 2026-06-01 |
| Study Of ATRN-119 In Patients With Advanced Solid Tumors ATRN-119 - Advanced Solid Tumor | Phase 1 / Phase 2 | Completed | Aprea Therapeutics | 43 | 2023-01-09 | 2026-08-04 |
Carcinoma, Squamous Cell (1) · Leukemia, Myeloid, Acute (1) · Papillomavirus Infections (1)
Abramson Cancer Center at Penn Medicine (1) · Aprea Therapeutics (1) · Washington University School of Medicine (1)
United States (2)
Crystal Miller, RN BSN (1) · Geoffrey L Uy, MD (1)
P50CA171963 (1)